MEDOVEX CORP's ticker is MDVX and the CUSIP is 58504H101. A total of 10 filers reported holding MEDOVEX CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $154,000 | +266.7% | 150,000 | +200.0% | 0.04% | +80.0% |
| Q2 2017 | $42,000 | -44.7% | 50,000 | 0.0% | 0.02% | -46.8% |
| Q1 2017 | $76,000 | +15.2% | 50,000 | 0.0% | 0.05% | +6.8% |
| Q4 2016 | $66,000 | -10.8% | 50,000 | 0.0% | 0.04% | -12.0% |
| Q3 2016 | $74,000 | +12.1% | 50,000 | 0.0% | 0.05% | +11.1% |
| Q2 2016 | $66,000 | +26.9% | 50,000 | 0.0% | 0.04% | +25.0% |
| Q1 2016 | $52,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MERIDIAN INVESTMENT COUNSEL INC. | 50,000 | $76,000 | 0.05% |
| FNY Partners Fund LP | 8,300 | $12,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 37 | $0 | 0.00% |
| NORTHERN TRUST CORP | 12,539 | $19,000 | 0.00% |
| BlackRock Inc. | 5,147 | $8,000 | 0.00% |
| VANGUARD GROUP INC | 38,598 | $59,000 | 0.00% |